Skip to content
AnalystLens

James Hardie Industries Annual Report, Year Ended Mar 31, 2018

Filing Date
Filed May 22, 2018
Period End
March 31, 2018
Securities
JHXJHIUF
One revenue dollarkept$0.07
In the record · 2016–202610-K1210-Q18-K401

JHX filed 12 annual reports (10-K), 1 quarterly reports (10-Q) and 401 current reports (8-K) between 2016 and 2026.

  1. Leadership change8-K · Oct ’26Oct ’26

Summary

Summary of the 20-F filed May 22, 2018. Cited figures are marked; the original filing is the authoritative source.

James Hardie Industries plc, filing its annual report on Form 20-F for the fiscal year ended 31 March 2018, reported net sales of $2,054.5 milliona, up from $1,921.6 million in fiscal 2017, with gross profit of $730.2 million.

Net income fell to $146.1 millionb from $276.5 million, driven mainly by an unfavorable asbestos adjustment of $156.4 million (versus a $40.4 million benefit in fiscal 2017), a $26.1 million loss on early debt extinguishment, and $10.0 million of Fermacell acquisition costs. Diluted EPS was $0.33, compared with $0.62 a year earlier. Adjusted net income, a non-GAAP measure the company presents, was $291.3 million.

North America Fiber Cement remained the largest segment, with net sales of $1,578.1 millionc and operating income of $381.9 million. International Fiber Cement reported net sales of $461.7 million and operating income of $108.4 million. Cash provided by operating activities was $295.0 million, and capital expenditures rose to $203.7 million, largely for the Tacoma greenfield expansion.

Net debt increased to $602.8 milliond at 31 March 2018 from $485.6 million a year earlier. Subsequent to year end, on 3 April 2018, the company completed the acquisition of Fermacell for an enterprise value of €473.0 million, funded partly by a €400.0 million drawdown on a 364-day term loan.

The company also issued US$800.0 million of senior notes in December 2017 and redeemed its 5.875% notes due 2023. Beginning in fiscal 2019, it plans to report a new European Building Products segment.

Key Highlights

  1. Net sales rose to $2,054.5 million, up from $1,921.6 million in fiscal 2017, with North America Fiber Cement contributing $1,578.1 million.
  2. Net income declined to $146.1 million from $276.5 million, mainly because of a $156.4 million asbestos adjustment expense versus a $40.4 million benefit in fiscal 2017.
  3. Diluted EPS was $0.33 versus $0.62 in fiscal 2017; adjusted diluted EPS, a non-GAAP measure, was $0.66.
  4. Operating cash flow was $295.0 million, while capital expenditures increased to $203.7 million from $101.9 million, mainly for the Tacoma greenfield expansion.
  5. Net debt rose to $602.8 million at 31 March 2018 from $485.6 million, and the company issued $800.0 million of senior notes in December 2017.
  6. The acquisition of Fermacell for an enterprise value of €473.0 million was completed on 3 April 2018, after the fiscal year end.
  7. The company expects an AICF contribution of approximately US$103.0 million on 2 July 2018, equal to 35% of free cash flow as defined by the AFFA.

Follow one dollar

Of each $1.00 of revenue in FY2018, James Hardie Industries kept $0.07.

  1. Revenue$2.05B100.0%
  2. Cost of revenue−$1.32B64.5%
  3. Gross profit$730.2M35.5%
  4. Operating costs−$501.0M24.4%
  5. Operating income$229.2M11.2%
  6. Interest, other & tax−$83.1M4.0%
  7. Net income$146.1M7.1%
Computed from 10-KFY2018filed May 22, 2018Computed from this filing’s revenue, gross profit, operating income and net income · right columngrey figure: share of revenue

Where FY2018 revenue went

$2.05B
  • Cost of revenue: $1.32B, 64% of revenue
  • SG&A: $311.3M, 15% of revenue
  • Net income: $146.1M, 7.1% of revenue
  • R&D: $33.3M, 1.6% of revenue
  • Other operating costs: $156.4M, 7.6% of revenue
  • Interest, other & tax: $83.1M, 4.0% of revenue

Kept 7.1% as net incomeR&D $33.3M · 1.6%

Full revenue history →

Financial Statements

FY2018 against FY2017

Line itemFY2018FY2017Change
Revenue$2.05B$1.92B+6.9%
Cost of Revenue$1.32B$1.25B+6.2%
Gross Profit$730.20M$674.70M+8.2%
R&D Expenses$33.30M$30.30M+9.9%
SG&A Expenses$311.30M$291.60M+6.8%
Operating Income$229.20M$393.20M−41.7%
Interest Expense$32.90M$28.50M+15.4%
Net Income$146.10M$276.50M−47.2%
EPS (Basic)$0.33$0.62−46.8%
EPS (Diluted)$0.33$0.62−46.8%
Shares Outstanding (Basic)441.20M442.70M−0.3%
Shares Outstanding (Diluted)442.30M443.90M−0.4%

Frequently Asked Questions

  1. Why did net income fall sharply in fiscal 2018?

    Net income fell to $146.1 million from $276.5 million. The filing attributes the decline primarily to an unfavorable asbestos adjustment of $156.4 million, which reflects an unfavorable actuarial adjustment and foreign exchange remeasurement. It also cites a $26.1 million loss on early debt extinguishment and $10.0 million of Fermacell acquisition costs.

  2. How did the core fiber cement businesses perform?

    North America Fiber Cement net sales increased to $1,578.1 million, and segment operating income rose to $381.9 million. International Fiber Cement net sales increased to $461.7 million, and segment operating income rose to $108.4 million. Gross margin in North America increased 0.6 percentage points, mainly from higher average net sales price.

  3. What is the company's key asbestos-related obligation?

    Through the AFFA, the Performing Subsidiary makes annual payments to AICF, generally 35% of free cash flow as defined in the agreement. The company recorded a gross asbestos liability of $1,215.1 million at 31 March 2018. It expects a payment of approximately $103.0 million on 2 July 2018.

  4. What changes to segment reporting and the business are expected?

    Beginning with the first quarter of fiscal 2019, the company intends to report a European Building Products segment that includes the existing European fiber cement business and the newly acquired Fermacell business. The International Fiber Cement segment will be renamed Asia Pacific Fiber Cement.